Predictive factors for retention of golimumab over a median 4-year duration in Japanese patients with rheumatoid arthritis in a real-world setting: A retrospective study and literature review.
Tomoyuki MutohTaichi NagaiTsuyoshi ShiraiSoshi OkazakiHiroko SatoHiroshi FujiiPublished in: International journal of rheumatic diseases (2022)
Prior exposure of increasing number of biologics was identified as the most important factor negatively affecting long-term golimumab retention in Japanese patients with RA.